PsychedelicNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Announces Purchase Order from British Columbia Liquor Distribution Branch

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, has received an initial purchase order (“PO”) for its proprietary cannabis vape cartridges through its wholly owned subsidiary Pure Extracts Manufacturing Corp. The PO, which is an initial order for the company’s 1-gram, full-spectrum oil (“FSO”), cannabis vape cartridges, was received from the Liquor Distribution Branch (“LDB”). According to the announcement, demand for Pure Extracts’ Pure Pulls branded vape carts is growing as consumer preferences mature and trend toward larger cartridges. Pure Extract’s 510 vape cartridges are produced by a global manufacturer and meet the highest North American test standards. LDB chose PULL’s cartridges for the quality of their component parts as well as their fit and finish and their performance characteristics; the cartridges will be filled with a selection of some of Pure Extract’s more than 30 proprietary cannabis FSO formulations. “We are excited to have received our first PO for 1 gram vape cartridges from the LDB, responsible for the wholesale distribution and retail sale of nonmedical cannabis in BC,” said Pure Extracts Technologies Corp. CEO Ben Nikolaevsky in the press release. “The combination of a larger format offering with our exceptional cannabis extracts will definitely build on the loyal following Pure Pulls already has in place. We are proud to be a leading innovator in the cannabis vape sector and look forward to providing additional SKUs to the LDB.”

To view the full press release, visit https://ibn.fm/r75d8

About Pure Extracts Technologies Corp.

Pure Extracts features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available. Health Canada, under the Cannabis Act, granted Pure Extracts its Standard Processing License on Sept. 25, 2020. In addition, the company’s stock began trading on the Canadian Securities Exchange (“CSE”) on Nov. 5, 2020. For more information about the company, please visit www.PureExtractsCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to PULL are available in the company’s newsroom at https://ibn.fm/PULL

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.psychedelicnewswire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.